These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11764939)

  • 41. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
    Rees WA; Harkins JD; Lu M; Holland RE; Lehner AF; Tobin T; Chambers TM
    Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of in vitro and in vivo methods of evaluation of the efficacy of influenza virus hemagglutinin inhibitors].
    Goncharova EP; Bylychev LE; Rak SV; P'iankova OG; Poryvaev VD; Ryzhikov AB
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (5):39-46. PubMed ID: 16981492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
    Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E
    Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of the times of remantadine administration on its content in MDCK cells and white mouse lung tissues infected and uninfected with the influenza virus].
    Kiseleva IV; Korchanova NL
    Vopr Virusol; 1982; 27(3):297-301. PubMed ID: 7123910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-Anhydro-6-hydroxy-ophiobolin A displays high in vitro and in vivo efficacy against influenza A virus infection.
    Wang S; Luo X; Yan R; Wang Q; Qi Q; Chi X; Zhang L; Yu Z; Cai B; Chen JL; Liu H
    Protein Cell; 2016 Nov; 7(11):839-843. PubMed ID: 27743345
    [No Abstract]   [Full Text] [Related]  

  • 47. A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
    Marra F; Marra CA; Stiver HG
    Can Respir J; 2003 Oct; 10(7):381-8. PubMed ID: 14571290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of the effect of rimantadine on the course of mixed viral-bacterial infection in albino mice].
    Zastavnyĭ IV; Shablovskaia EA; Loziuk LV; Volos OP; Shloma BV
    Vopr Virusol; 1978; (1):79-81. PubMed ID: 347720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Factors of antiviral resistance in the pathogenesis of influenza in mice].
    Chetverikova LK; Ki'ldivatov IIu; Inozemtseva LI; Kramskaia TA; Filippov VK; Frolov BA
    Vestn Akad Med Nauk SSSR; 1989; (11):63-8. PubMed ID: 2623936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Virus-inhibiting properties of the carbonyl-conjugated pentaene roseofungin].
    Shneĭder MA; Shtil'bans EB; Rachkovskaia LA; Vetlugina LA; Nikitina ET
    Antibiotiki; 1984 May; 29(5):344-9. PubMed ID: 6331293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiviral action of a polyphenol complex isolated from the medicinal plant Geranium sanguineum L. I. Its inhibiting action on the reproduction of the influenza virus].
    Manolova N; Gegova G; Serkedzhieva Iu; Maksimova-Todorova V; Uzunov S
    Acta Microbiol Bulg; 1986; 18():73-7. PubMed ID: 3776704
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiviral flavonoids from Mosla scabra.
    Wu Q; Yu C; Yan Y; Chen J; Zhang C; Wen X
    Fitoterapia; 2010 Jul; 81(5):429-33. PubMed ID: 20006976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined protective effect of an immunostimulatory bacterial preparation and rimantadine in experimental influenza A virus infection.
    Serkedjieva J; Ivanova E
    Acta Virol; 1997 Apr; 41(2):65-70. PubMed ID: 9219635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.
    Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M
    Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton].
    Gerasina SF; Farashian VR; Fadeeva NI; Pershin GN; Zhdanov VM
    Farmakol Toksikol; 1985; 48(4):92-5. PubMed ID: 2412888
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
    Webster RG; Kawaoka Y; Bean WJ
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():157-64. PubMed ID: 3793657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of remantadine on the course of influenzal infection in immunosuppressed mice].
    Alavidze MO; Kupradze SA; Bakhutashvili VI; Galegov GA
    Vopr Virusol; 1983; 28(6):726-8. PubMed ID: 6670257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combinations of antiviral agents for treatment of influenza virus infections.
    Hayden FG
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():177-83. PubMed ID: 3793658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.